La cadena de opciones muestra datos clave de las opciones de acciones de Simply Good Foods a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Simply Good Foods..

Simply Good Foods (NASDAQ:SMPL) Bolsa, Cadena de Opciones

Simply Good Foods

The Simply Good Foods Co is a consumer packaged food and beverage company. It provides low-carbohydrate, high protein bars, shakes, and other products such as confections, chips, and cookies under the Atkins and Quest brands. The company distributes its products in retail channels, predominantly in North America, including grocery, club, and mass merchandise, as well as through e-commerce, convenience, and other channels. It derives maximum revenue from North America.

Delta Air Lines Jet Overturns At Toronto Pearson Airport Amid Snowstorm — 18 Injured, 3 Critical

Equities

News

Pre-Market Outlook

Markets

Trading Ideas

AEHR

KRUS

SMPL

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este miércoles: DAL, KRUS, SMPL, AEHR y STZ.

5 acciones en el foco este miércoles: DAL, KRUS, SMPL, AEHR y STZ

The Simply Good Foods Company - Common Stock

The Simply Good Foods Co

Options

MANU

Manchester United Option Alert: Sep 19 $25 Calls Sweep (5) near the Ask: 1888 @ $0.438 vs 8260 OI; Ref=$18.135

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Opinion

CRCL

Circle (CRCL): Why I Am Issuing A Strong Buy Rating

AIFF

Firefly Neuroscience To Be Added To Russell Microcap Index, Effective June 30, 2025, As Part Of 2025 Reconstitution

Barclays analyst Theresa Chen maintains Kinder Morgan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>) with a Overweight and raises the price target from $31 to $32.

Price Target

Analyst Ratings

Barclays Maintains Overweight on Kinder Morgan, Raises Price Target to $32

Barclays analyst Jeffrey Bernstein maintains Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) with a Overweight and raises the price target from $235 to $255.

Barclays Maintains Overweight on Darden Restaurants, Raises Price Target to $255

Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) has outperformed the market over the past 5 years by 8.26% on an annualized basis producing an average annual return of 23.01%. Currently, Charles Schwab has a market capitalization of $162.53 billion. 
Buying $1000 In SCHW: If an investor had bought $1000 of SCHW stock 5 years ago, it would be worth $2,624.41 today based on a price of $89.45 for SCHW at the time of writing.
<h3>Charles Schwab's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750688129_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SCHW

Here's How Much You Would Have Made Owning Charles Schwab Stock In The Last 5 Years

Being a child star looks like an idyllic life, but the entertainment industry landscape is littered with former prodigies who grew up to struggle with financial hardship. Jami Gertz is not going to be one of them. That's partly because she's moved from the silver screen to the boardroom, where she is co-owner of the NBA's Atlanta Hawks.&nbsp;
The 59-year-old Gertz began her career in 1982 as a regular on the CBS show "Square Pegs," and also appeared in hit shows such as "Diff'rent Strokes" and "Family Ties." At the peak of her fame, Gertz played a leading role in vampire movie "The Lost Boys," which is widely hailed as a cult classic that became synonymous with the 80s generation.
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">invest with $1,000 at just $0.30/share.</a></li>
</ul>
Although "The Lost Boys" didn't propel Gertz into bona fide stardom, her work on the film is notable for another reason. While she was filming, Gertz's publicist introduced her to Tony Ressler, a banker for Drexel-Burnham Lambert. They became a couple and got married two years later.
During the early years of their marriage, Gertz continued acting and made appearances on "Ally McBeal," "Seinfeld," and "ER." Her last major role came as Dr. Melissa Reeves, the wife of Bill Paxton's character in the 1996 hit, "Twister." All the while, Ressler quietly built his reputation and fortune as a businessman. After the collapse of Drexel Burnham, he co-founded Apollo Global Management (NYSE:<a href="https://www.benzinga.com/quote/APO/news"> APO</a>) with Leon Black in 1990.
In 2015, the couple joined a group that included NBA Hall-of-Famer Grant Hill and purchased the Atlanta Hawks. Gertz recounted the tale in an interview with<a href="https://www.hollywoodreporter.com/business/business-news/how-jami-gertz-became-a-hollywood-nba-owner-1150556/"> The Hollywood Reporter</a>. &#8220;He [Ressler] has a little tiny desk in there, and he was taking calls in the closet,&#8221; Gertz said. &#8220;I was walking in and out of the closet. And he looked at me, and I looked at him, and he&#8217;s like, &#8216;Jami, are we going to do this?&#8217; I&#8217;m like, &#8216;I don&#8217;t know. I&#8217;m so scared.&#8217; And he&#8217;s like, &#8216;It would be so much fun.&#8217; And then we were jumping and screaming, &#8216;Oh my God — we just bought a basketball team!'&#8221;&nbsp;&nbsp;
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.
Gertz suddenly found herself in familiar territory: the spotlight. It wasn't Hollywood, but Ressler told the Hollywood Reporter his wife wasted no time in making her presence felt. Her official "coming out party" came when she represented the Hawks at the 2018 NBA Draft Lottery. Since then, Gertz's role with the Hawks has only increased, and she has thrown herself into the franchise.
Gertz and Ressler relocated to Atlanta in 2017, a move that caused her to put her acting career on hold. She has embraced her new role in Atlanta wholeheartedly.&nbsp; &#8220;It just seemed like a natural moment for me to take a break from acting,&#8221; she said. &#8220;It&#8217;s hard to even say it out loud, because I love what I do. It&#8217;s given me so many beautiful things in my life, taught me so many things about myself and the world around me.&#8221;
The team is much better off for Gertz's and Ressler's involvement. They were active participants in a $192 million renovation of the team&#8217;s stadium and in building a new 90,000 square foot practice facility. Gertz continues to put her stamp on the team by overseeing internal operations and focusing on making sure Hawks fans have a great time when they come to see the team. She sees it as an essential aspect of running a first-class NBA franchise.
See Also: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a>
"I bought tickets when I couldn't afford them. I worked hard enough where I could eventually become a season ticket holder," she told<a href="https://www.peachtreehoops.com/2020/8/19/21373731/jami-gertz-atlanta-hawks-nba-draft-lottery-2020-owner-interview-comments-tony-ressler"> Peachtreehoops.com</a>. "So, I'm coming from that fan experience, being in L.A., and seeing where there was great food, and then the food wasn't so good. All of those things. I care a ton about fan experience." Gertz is also thinking about the basketball side of the operation.
Ressler and his team handle the player transactions and long-term roster planning. However, he is just as committed to making Atlanta a championship-caliber<a href="https://www.benzinga.com/markets/24/02/36894409/franchises-in-the-united-states-three-keys-that-can-pave-the-way-to-business-success-in-the-american"> franchise</a> as Gertz is to creating a championship-caliber fan experience. It will take lots of hard work for Ressler and Gertz to make their <a href="https://www.benzinga.com/money/high-return-investments">investment</a> in the Atlanta Hawks pay off. So far, the on-court results have not been spectacular, but they are committed to Atlanta for the long haul.
Read Next: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
Image: Shutterstock

All Grown Up-The 80's Child Star That's Now Co-Owner Of The NBA's Atlanta Hawks

Kingstone Companies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KINS#NASDAQ">KINS</a>) (the "Company" or "Kingstone"), a Northeast regional property and casualty insurance holding company, today announced that its catastrophe reinsurance program for the period July 1, 2025 through June 30, 2026 has been finalized.
Meryl Golden, Chief Executive Officer at Kingstone, stated, "I am pleased to announce the successful completion of our 2025/2026 catastrophe reinsurance placement with favorable economic terms. In response to the significant growth in premium and exposure experienced in the past year, we increased our catastrophe reinsurance limit by 57%, or $160 million, to $440 million. The limit includes multi-year protection of $125 million sourced through the issuance of our first catastrophe bond, 1886 Re Ltd., as announced in May.

KINS

Kingstone Companies Finalizes Catastrophe Reinsurance Program For Period July 1, 2025 Through June 30, 2026; Increases Catastrophe Reinsurance Limit By 57%, Or $160M, To $440M

<a href="https://x.com/citronresearch/status/1937151090258333972?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg">https://x.com/citronresearch/status/1937151090258333972?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg</a>

General

TDOC

Citron Research Posts On X "The Coiled Spring Wall The world's largest Telehealth platform now trades at just a $1.2B market cap — yet it quietly owns BetterHelp, the #1 brand in online therapy. Until now, BetterHelp operated as cash-pay only, and that meant 80% of potential users walked..."

Barclays analyst Pablo Monsivais maintains Corporacion Inmobiliaria (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTMX#NYSE">VTMX</a>) with a Overweight and raises the price target from $34 to $37.

VTMX

Barclays Maintains Overweight on Corporacion Inmobiliaria, Raises Price Target to $37

Professional Capital Management CEO Anthony Pompliano has announced a $1 billion merger to launch ProCap Financial, a new <a href="https://www.benzinga.com/crypto">Bitcoin-focused financial services firm</a>.
The company, formed through a business combination with Columbus Circle Capital Corp. I (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCCM#NASDAQ">CCCM</a>), <a href="https://www.globenewswire.com/news-release/2025/06/23/3103348/0/en/Anthony-Pompliano-Strikes-1-Billion-Merger-to-Create-ProCap-Financial-Raises-Over-750M-in-Largest-Initial-Fundraise-in-History-for-Public-Bitcoin-Treasury-Company.html">plans </a>to hold up to $1 billion worth of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) on its balance sheet.
The deal represents the largest initial fundraising in history for a publicly traded Bitcoin treasury company: $516.5 million in equity and $235 million in convertible notes.
Pompliano's venture secured backing from a mix of institutional and crypto-native investors including Magnetar Capital, Woodline Partners, Anson Funds, RK Capital, Off the Chain Capital, Parafi, Blockchain.com, Arrington Capital, BSQ Capital Partners, and FalconX. 
Morgan Creek Capital founder Mark Yusko, Main Street Ventures founder Jason Williams, Semler Scientific&#8217;s Eric Semler, renowned poker player Tony Guoga, and Eight Sleep CEO Matteo Franceschetti also participated.
ProCap Financial aims to actively acquire bitcoin and generate revenue from its holdings through diversified, risk-managed strategies. 
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46050168/investors-poured-billions-into-bitcoin-and-ethereum-even-as-iran-israel-tensions-escalated">Investors Poured Billions Into Bitcoin And Ethereum Even As Iran-Israel Tensions Escalated</a>
&#8220;The legacy financial system is being disrupted by Bitcoin. ProCap Financial represents our solution to the increasing demand for Bitcoin-native financial services among sophisticated investors,&#8221; Pompliano said.
The company plans to offer financial services that leverage its bitcoin treasury. It aims to position itself as a leader in the emerging market for digital asset-backed financial platforms.
ProCap's public listing will provide equity investors with immediate exposure to Bitcoin through the company's balance sheet structure.
The merger and initial capital raise signal growing institutional appetite for Bitcoin treasury companies, a trend previously accelerated by firms like MicroStrategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) and Metaplanet, which have aggressively accumulated bitcoin to diversify their corporate treasuries.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46034531/this-record-credential-leak-could-change-how-you-log-in-forever-heres-why">This Record Credential Leak Could Change How You Log In Forever —Here&#8217;s Why</a></li>
</ul>
Image: Shutterstock

$BTC

CCCM

MSTR

Anthony Pompliano Unveils ProCap Financial With $1B Bitcoin Treasury After $750M Fundraise

Barclays analyst Terry Ma maintains Capital One Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) with a Overweight and raises the price target from $212 to $253.

Barclays Maintains Overweight on Capital One Finl, Raises Price Target to $253

Alpha Modus Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMOD#NASDAQ">AMOD</a>), a retail AI and data monetization company, today announced a major personal capital commitment from its CEO William Alessi to further support the company's rapid growth and operational plans for the remainder of 2025.
In a strong display of confidence, Mr. Alessi and his affiliated family trusts have recently completed the exchange of a substantial block of preferred shares into common stock, aligning long-term interests with shareholders. Now, he has personally committed up to $3 million in simple debt financing to ensure Alpha Modus remains well-capitalized and strategically focused through year-end while rejecting all third-party derivative financing offerings.
The company has applied to transfer its securities listing to the NASDAQ Capital Market and believes it will be compliant with all applicable Nasdaq listing standards upon transfer.
Alpha Modus intends to maintain a lean operational model with strategic financial support from its CEO, and it is focused on avoiding all variable rate financing in the future, which financing could compromise the value of its common shares.

AMOD

Alpha Modus Announces $3M Personal Capital Commitment From CEO William Alessi To Further Support Company's Growth And Operational Plans For Remainder Of 2025

Barclays analyst Ramsey El-Assal maintains Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) with a Overweight and lowers the price target from $390 to $360.

Barclays Maintains Overweight on Accenture, Lowers Price Target to $360

Groundbreaking First-in-Human Study Establishes Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression
Six-Month Patient Follow-up Results Demonstrate that Sana's Transplanted Pancreatic Islet Cells Modified with its Hypoimmune (HIP) Technology are Safe and Well-tolerated, Survive, Evade Detection by the Immune System, and Continue to Produce Insulin in the Patient
Function and Persistence of Pancreatic Islets Were Detectable by Production of Consistent Levels of Circulating C-Peptide, a Marker of Insulin Production, and Increased C-Peptide Levels with a Mixed Meal Tolerance Test (MMTT)
MRI Show Signals Consistent with Graft Survival Six Months after Transplantation
Study Continues to Evaluate Safety, Survival, and Function of Transplanted Cells
Data Shared at an Invited Presentation at the 85th Annual American Diabetes Association (ADA) Scientific Sessions Today
Sana is Incorporating the Tested Immune Evasion Technology to Develop SC451, a HIP-modified, Stem Cell-Derived Therapy as a One-Time Treatment for Patients with Type 1 Diabetes, with a Goal of Normal Blood Glucose, with No Insulin and No Immunosuppression
SEATTLE, June 23, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANA#NASDAQ">SANA</a>), a company focused on changing the possible for patients through engineered cells, today announced six-month follow-up results from an investigator-sponsored, first-in-human study transplanting UP421, an allogeneic primary islet cell therapy engineered with Sana's hypoimmune (HIP) technology, into a patient with type 1 diabetes without any immunosuppression. The study is being conducted in partnership with Uppsala University Hospital. The results are consistent with and build upon the previously reported four-week and 12-week clinical results. Results of the study at six months after cell transplantation demonstrate the survival and function of pancreatic beta cells as measured by the presence of circulating C-peptide, a biomarker indicating that transplanted beta cells are producing insulin. C-peptide levels also increase with a mixed meal tolerance test (MMTT), consistent with insulin secretion in response to a meal. 12-week PET-MRI scanning also demonstrated islet cells at the transplant site, a forearm muscle. The study identified no safety issues, and the HIP-modified islet cells evaded immune responses.

SANA

Sana Biotechnology Announces 6-Month Follow-Up Results From First-In-Human Study Transplanting UP421, Allogeneic Primary Islet Cell Therapy Engineered With Sana's HIP Technology, Into Patient With T1D Without Any Immunosuppression

<a href="https://www.cnb.cz/en/economic-research/conferences-seminars-and-workshops/assessing-the-effectiveness-of-monetary-policy-during-and-after-the-covid-19-pandemic/">https://www.cnb.cz/en/economic-research/conferences-seminars-and-workshops/assessing-the-effectiveness-of-monetary-policy-during-and-after-the-covid-19-pandemic/</a>

Politics

Economics

Federal Reserve

Fed's Bowman Says Data Not Showing Much Impact From Trade Policy Shifts; Government Policy Changes Should Lower Inflation Risks; Tariffs Likely To Have Small Impact On Inflation; Progress On Trade Has Lowered Uncertainty Over Outlook; Current Middle East Strife Could Pressure Up Commodity Prices;  Labor Market Solid, But Signs Of Softness Emerging

Research also shows a reversal of the gender pay gap under VBC
agilon health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>), the trusted partner empowering physicians to transform health care in our communities, today announced the publication of new peer-reviewed data examining the impact of gender differences of primary care physicians (PCPs) on patient outcomes, healthcare utilization and revenue using different Medicare payment models, specifically value-based care (VBC) and fee-for-service (FFS). Research was published in the May 16, 2025, issue of the JAMA Health Forum.

agilon health Announces Publication Of New Peer-Reviewed Data Examining Impact Of Gender Differences Of PCPs On Patient Outcomes, Healthcare Utilization And Revenue Using Different Medicare Payment Models

Macro Economic Events

Fed's Bowman Says Open To Cutting Rates As Soon As July FOMC Meeting If Inflation Pressures Stay Contained; Should Put More Weight On Downside Risks To Job Market Going Forward; Says 'It Is Time To Consider Adjusting The Policy Rate'; Trade Policy Only Likely To Have 'Minimal Impacts' On Inflation

Whales with a lot of money to spend have taken a noticeably bullish stance on Meta Platforms.
Looking at options history for Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) we detected 29 trades.
If we consider the specifics of each trade, it is accurate to state that 48% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $379,476 and 21, calls, for a total amount of $1,250,959.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $5.0 and $720.0 for Meta Platforms, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Meta Platforms's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Meta Platforms's whale activity within a strike price range from $5.0 to $720.0 in the last 30 days. 
<h3>Meta Platforms Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750687372_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>META</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/03/25</td>
<td>$27.7</td>
<td>$27.15</td>
<td>$27.55</td>
<td>$660.00</td>
<td>$272.7K</td>
<td>409</td>
<td>230</td>
</tr>
<tr>
<td>META</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$61.6</td>
<td>$60.85</td>
<td>$60.85</td>
<td>$630.00</td>
<td>$91.2K</td>
<td>2.7K</td>
<td>16</td>
</tr>
<tr>
<td>META</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/11/25</td>
<td>$16.7</td>
<td>$16.0</td>
<td>$16.0</td>
<td>$685.00</td>
<td>$80.0K</td>
<td>262</td>
<td>56</td>
</tr>
<tr>
<td>META</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/25/25</td>
<td>$32.95</td>
<td>$29.95</td>
<td>$31.75</td>
<td>$700.00</td>
<td>$79.3K</td>
<td>155</td>
<td>0</td>
</tr>
<tr>
<td>META</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/27/25</td>
<td>$3.4</td>
<td>$3.35</td>
<td>$3.4</td>
<td>$700.00</td>
<td>$76.8K</td>
<td>6.2K</td>
<td>1.7K</td>
</tr>
</tbody>
</table>

<h3>About Meta Platforms</h3>
Meta is the largest social media company in the world, boasting close to 4 billion monthly active users worldwide. The firm's "Family of Apps," its core business, consists of Facebook, Instagram, Messenger, and WhatsApp. End users can leverage these applications for a variety of different purposes, from keeping in touch with friends to following celebrities and running digital businesses for free. Meta packages customer data, gleaned from its application ecosystem and sells ads to digital advertisers. While the firm has been investing heavily in its Reality Labs business, it remains a very small part of Meta's overall sales.
After a thorough review of the options trading surrounding Meta Platforms, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Meta Platforms</h3>
<ul>
<li>With a volume of 1,289,155, the price of META is down -0.04% at $682.09. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 37 days.</li>
</ul>
<h3>Expert Opinions on Meta Platforms</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $737.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Meta Platforms, targeting a price of $775. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $676. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Meta Platforms with a target price of $664. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Meta Platforms with a target price of $765. 
&#x2A; An analyst from Cantor Fitzgerald has decided to maintain their Overweight rating on Meta Platforms, which currently sits at a price target of $807. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Meta Platforms, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Spotlight on Meta Platforms: Analyzing the Surge in Options Activity

Financial giants have made a conspicuous bearish move on Boeing. Our analysis of options history for Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) revealed 9 unusual trades.
Delving into the details, we found 33% of traders were bullish, while 44% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $117,270, and 7 were calls, valued at $448,575.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $200.0 to $300.0 for Boeing over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Boeing's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Boeing's substantial trades, within a strike price spectrum from $200.0 to $300.0 over the preceding 30 days.
<h3>Boeing Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750687367_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$5.9</td>
<td>$5.85</td>
<td>$5.9</td>
<td>$210.00</td>
<td>$118.0K</td>
<td>4.8K</td>
<td align="right">15</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$9.3</td>
<td>$9.1</td>
<td>$9.17</td>
<td>$210.00</td>
<td>$91.7K</td>
<td>10.3K</td>
<td align="right">102</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/03/25</td>
<td>$3.7</td>
<td>$3.65</td>
<td>$3.7</td>
<td>$200.00</td>
<td>$74.0K</td>
<td>1.3K</td>
<td align="right">212</td>
</tr>
<tr>
<td>BA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$14.05</td>
<td>$12.6</td>
<td>$13.35</td>
<td>$200.00</td>
<td>$66.7K</td>
<td>1.1K</td>
<td align="right">0</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$3.35</td>
<td>$3.3</td>
<td>$3.3</td>
<td>$220.00</td>
<td>$66.0K</td>
<td>3.1K</td>
<td align="right">215</td>
</tr>
</tbody>
</table>

<h3>About Boeing</h3>
Boeing is a major aerospace and defense firm. It operates in three segments: commercial airplanes; defense, space, and security; and global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with defense contractors such as Lockheed Martin and Northrop Grumman to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.
After a thorough review of the options trading surrounding Boeing, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Boeing's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 485,690, the BA's price is up by 0.01%, now at $198.76. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 37 days.</li>
</ul>
<h3>Professional Analyst Ratings for Boeing</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $230.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Boeing with a target price of $230. 
&#x2A; In a cautious move, an analyst from Morgan Stanley downgraded its rating to Equal-Weight, setting a price target of $200. 
&#x2A; Consistent in their evaluation, an analyst from Jefferies keeps a Buy rating on Boeing with a target price of $250. 
&#x2A; An analyst from Goldman Sachs has revised its rating downward to Buy, adjusting the price target to $212. 
&#x2A; An analyst from B of A Securities upgraded its action to Buy with a price target of $260. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Boeing with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Comments

Simply Good Foods

Simply Good Foods (SMPL) Opciones

Simply Good Foods (NASDAQ:SMPL) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL